Stryker to Buy Entellus Medical For $662 Million

Date : 12/07/2017 @ 2:15PM
Source : Dow Jones News
Stock : Entellus Medical, Inc. (delisted) (ENTL)
Quote : 24.0  0.0 (0.00%) @ 7:05AM

Stryker to Buy Entellus Medical For $662 Million

Stryker (NYSE:SYK)
Historical Stock Chart

2 Years : From Dec 2016 to Dec 2018

Click Here for more Stryker Charts.
   By Austen Hufford 

Stryker Corp. (SYK) is buying Entellus Medical Inc. (ENTL) for about $662 million, or $24 a share.

Entellus makes products for the minimally invasive treatment of chronic and recurrent sinusitis, a condition where sinuses become infected. The deal's value is a 49% premium over the company's closing price Wednesday.

Entellus was founded in 2006 and is headquartered in Plymouth, Minn.

Stryker said the business is complementary to the existing ear, nose, and throat portfolio of its instruments business.

The transaction is expected to dent Stryker's 2018 adjusted net earnings per share by about 4 cents and then add to per-share earnings afterward.

Entellus had revenue of $75.2 million in 2016 and reported a net loss of $28.7 million.


Write to Austen Hufford at


(END) Dow Jones Newswires

December 07, 2017 09:00 ET (14:00 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.

Latest ENTL Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.